Investec is acting as sole financial adviser to bd-capital on its £82m recommended acquisition of Science in Sport plc
Our role
Our UK Consumer M&A advisory team is acting as sole financial adviser to bd-capital on its £82 million recommended acquisition of Science in Sport plc (“SiS”), a leading provider of sports nutrition for athletes, sports and fitness enthusiasts.
This transaction is our UK Advisory team’s 11th UK public M&A transaction in the last 16 months and marks our first deal with bd-capital.
About bd-capital
- bd-capital was founded in 2019 by Andrew Dawson (former Partner at Advent International), and Richard Baker (former FTSE 100 CEO and Chairman, and Advent Operating Partner). bd-capital is a private equity firm that follows an operator-led investment strategy, making majority investments in mid-market businesses headquartered in the UK, Benelux and Iberia, which operate in industries that are experiencing enduring structural growth across the Healthcare, Services and Consumer sectors.
- bd-capital has raised two funds since its inception, and, currently, has over €800 million in assets under management. bd-capital’s second fund closed in March 2025 with total commitments of €430 million, exceeding the initial target by 20 per cent.
About Science in Sport plc
- SiS is a leading sports nutrition business that develops, manufactures, and markets innovative nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community with production facilities based in Blackburn, UK. SiS was admitted to trading on AIM in August 2013 and its market capitalisation at the Latest Practicable Date was approximately £63.9 million.
- SiS has two highly regarded brands: PhD, a premium active-nutrition brand targeting the active lifestyle community; and SiS, a leading endurance nutrition brand for elite athletes and professional sports teams.
